Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cost of Goods | N/A | N/A | N/A | 5,335 | 4,190 |
| Gross Profit | N/A | N/A | N/A | -5,335 | -4,190 |
| Operating Expenses | 18,823 | 23,899 | 36,688 | 23,215 | 15,853 |
| Operating Income | -18,823 | -23,899 | -36,688 | -28,549 | -20,043 |
| Other Income | 210 | 371 | 345 | -455 | 77 |
| Pre-tax Income | -18,613 | -23,527 | -36,343 | -29,005 | -19,966 |
| Income Tax | 7 | 5 | 30 | 40 | 8 |
| Net Income Continuous | -18,619 | -23,533 | -36,374 | -29,045 | -19,974 |
| Net Income | $-18,619 | $-23,533 | $-36,374 | $-29,045 | $-19,974 |
| EPS Basic Total Ops | -2.00 | -2.66 | -4.56 | -3.90 | -3.04 |
| EPS Basic Continuous Ops | -2.00 | -2.66 | -4.56 | -3.90 | -3.04 |
| EPS Diluted Total Ops | -2.00 | -2.66 | -4.56 | -3.90 | -3.04 |
| EPS Diluted Continuous Ops | -2.00 | -2.66 | -4.56 | -3.90 | -3.04 |
| EBITDA(a) | $-18,659 | $-23,767 | $-36,579 | $-28,457 | $-19,980 |